{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:23:01Z","timestamp":1782566581578,"version":"3.54.5"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12640-020-00185-1","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T13:03:15Z","timestamp":1583845395000},"page":"8-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"38","author":[{"given":"Abdullah","family":"Al Mamun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-7840","authenticated-orcid":false,"given":"Md. Sahab","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Tanvir","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayema","family":"Khanum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Shahid","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muniruddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam Md","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"185_CR1","doi-asserted-by":"publisher","unstructured":"Al Mamun A, Uddin MS (2020) KDS2010: a potent highly selective and reversible MAO-B inhibitor to abate Alzheimer\u2019s disease. Comb Chem High Throughput Screen 23. https:\/\/doi.org\/10.2174\/1386207323666200117103144","DOI":"10.2174\/1386207323666200117103144"},{"issue":"80","key":"185_CR2","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.1141448","volume":"319","author":"WE Balch","year":"2008","unstructured":"Balch WE, Morimoto RI, Dillin A, Kelly JW (2008) Adapting proteostasis for disease intervention. Science 319(80):916\u2013919. https:\/\/doi.org\/10.1126\/science.1141448","journal-title":"Science"},{"key":"185_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1006\/EXMP.2002.2451","volume":"73","author":"F Bardag-Gorce","year":"2002","unstructured":"Bardag-Gorce F, van Leeuwen FW, Nguyen V, French BA, Li J, Riley N, McPhaul L, Lue YH, French SW (2002) The role of the ubiquitin\u2013proteasome pathway in the formation of Mallory bodies. Exp Mol Pathol 73:75\u201383. https:\/\/doi.org\/10.1006\/EXMP.2002.2451","journal-title":"Exp Mol Pathol"},{"key":"185_CR4","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1517\/14728222.2014.943185","volume":"18","author":"LJ Blair","year":"2014","unstructured":"Blair LJ, Sabbagh JJ, Dickey CA (2014) Targeting Hsp90 and its co-chaperones to treat Alzheimer\u2019s disease. Expert Opin Ther Targets 18:1219\u20131232. https:\/\/doi.org\/10.1517\/14728222.2014.943185","journal-title":"Expert Opin Ther Targets"},{"key":"185_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3233\/JAD-130779","volume":"38","author":"NV Bobkova","year":"2013","unstructured":"Bobkova NV, Garbuz DG, Nesterova I et al (2013) Therapeutic effect of exogenous Hsp70 in mouse models of Alzheimer\u2019s disease. J Alzheimers Dis 38:425\u2013435. https:\/\/doi.org\/10.3233\/JAD-130779","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"185_CR6","doi-asserted-by":"publisher","first-page":"e83096","DOI":"10.1371\/journal.pone.0083096","volume":"8","author":"Hianara A. Bustamante","year":"2013","unstructured":"Bustamante HA, Rivera-Dictter A, Cavieres VA et al (2013) Turnover of C99 is controlled by a crosstalk between ERAD and ubiquitin-independent lysosomal degradation in human neuroglioma cells. PLoS One 8. https:\/\/doi.org\/10.1371\/journal.pone.0083096","journal-title":"PLoS ONE"},{"key":"185_CR7","first-page":"84","volume":"1","author":"Z Cai","year":"2013","unstructured":"Cai Z, Yan L-J (2013) Rapamycin, autophagy, and Alzheimer\u2019s disease. J Biochem Pharmacol Res 1:84\u201390","journal-title":"J Biochem Pharmacol Res"},{"key":"185_CR8","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.bbadis.2012.07.015","volume":"1822","author":"V Cecarini","year":"2012","unstructured":"Cecarini V, Bonfili L, Cuccioloni M et al (2012) Crosstalk between the ubiquitin\u2013proteasome system and autophagy in a human cellular model of Alzheimer\u2019s disease. Biochim Biophys Acta 1822:1741\u20131751. https:\/\/doi.org\/10.1016\/j.bbadis.2012.07.015","journal-title":"Biochim Biophys Acta"},{"key":"185_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6564212","volume":"2016","author":"B Cheng","year":"2016","unstructured":"Cheng B, Anand P, Kuang A et al (2016) N-Acetylcysteine in combination with IGF-1 enhances neuroprotection against proteasome dysfunction-induced neurotoxicity in SH-SY5Y cells. Parkinsons Dis 2016:1\u201312. https:\/\/doi.org\/10.1155\/2016\/6564212","journal-title":"Parkinsons Dis"},{"key":"185_CR10","doi-asserted-by":"publisher","first-page":"314ra184","DOI":"10.1126\/scitranslmed.aad1904","volume":"7","author":"J Choi","year":"2015","unstructured":"Choi J, Gao J, Kim J et al (2015) The E3 ubiquitin ligase idol controls brain LDL receptor expression, ApoE clearance, and A\u03b2 amyloidosis. Sci Transl Med 7:314ra184. https:\/\/doi.org\/10.1126\/scitranslmed.aad1904","journal-title":"Sci Transl Med"},{"key":"185_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0092-8674(94)90396-4","volume":"79","author":"A Ciechanover","year":"1994","unstructured":"Ciechanover A (1994) The ubiquitin-proteasome proteolytic pathway. Cell 79:13\u201321. https:\/\/doi.org\/10.1016\/0092-8674(94)90396-4","journal-title":"Cell"},{"key":"185_CR12","doi-asserted-by":"publisher","first-page":"7151","DOI":"10.1093\/emboj\/17.24.7151","volume":"17","author":"A Ciechanover","year":"1998","unstructured":"Ciechanover A (1998) The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17:7151\u20137160. https:\/\/doi.org\/10.1093\/emboj\/17.24.7151","journal-title":"EMBO J"},{"key":"185_CR13","doi-asserted-by":"publisher","first-page":"10825","DOI":"10.1074\/jbc.M512786200","volume":"281","author":"D Cripps","year":"2006","unstructured":"Cripps D, Thomas SN, Jeng Y, Yang F, Davies P, Yang AJ (2006) Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. J Biol Chem 281:10825\u201310838. https:\/\/doi.org\/10.1074\/jbc.M512786200","journal-title":"J Biol Chem"},{"key":"185_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B De Strooper","year":"1998","unstructured":"De Strooper B, Saftig P, Craessaerts K et al (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391:387\u2013390. https:\/\/doi.org\/10.1038\/34910","journal-title":"Nature"},{"key":"185_CR15","doi-asserted-by":"publisher","first-page":"17294","DOI":"10.1074\/jbc.M500997200","volume":"280","author":"A Demuro","year":"2005","unstructured":"Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280:17294\u201317300. https:\/\/doi.org\/10.1074\/jbc.M500997200","journal-title":"J Biol Chem"},{"key":"185_CR16","doi-asserted-by":"publisher","first-page":"37276","DOI":"10.1074\/jbc.M706379200","volume":"282","author":"E Elliott","year":"2007","unstructured":"Elliott E, Tsvetkov P, Ginzburg I (2007) BAG-1 associates with Hsc70\u00b7tau complex and regulates the proteasomal degradation of tau protein. J Biol Chem 282:37276\u201337284. https:\/\/doi.org\/10.1074\/jbc.M706379200","journal-title":"J Biol Chem"},{"key":"185_CR17","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/j.1471-4159.2009.06047.x","volume":"109","author":"E Elliott","year":"2009","unstructured":"Elliott E, Laufer O, Ginzburg I (2009) BAG-1M is up-regulated in hippocampus of Alzheimer\u2019s disease patients and associates with tau and APP proteins. J Neurochem 109:1168\u20131178. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06047.x","journal-title":"J Neurochem"},{"key":"185_CR18","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1745-7270.2008.00441.x","volume":"40","author":"X Gao","year":"2008","unstructured":"Gao X, Hu H (2008) Quality control of the proteins associated with neurodegenerative diseases. Acta Biochim Biophys Sin Shanghai 40:612\u2013618. https:\/\/doi.org\/10.1111\/j.1745-7270.2008.00441.x","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"key":"185_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fnmol.2015.00047","volume":"8","author":"RJ Gentier","year":"2015","unstructured":"Gentier RJ, van Leeuwen FW (2015) Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer\u2019s disease. Front Mol Neurosci 8:47. https:\/\/doi.org\/10.3389\/fnmol.2015.00047","journal-title":"Front Mol Neurosci"},{"key":"185_CR20","doi-asserted-by":"publisher","first-page":"37436","DOI":"10.1038\/srep37436","volume":"6","author":"Y Gerakis","year":"2016","unstructured":"Gerakis Y, Dunys J, Bauer C, Checler F (2016) A\u03b242 oligomers modulate \u03b2-secretase through an XBP-1s-dependent pathway involving HRD1. Sci Rep 6:37436. https:\/\/doi.org\/10.1038\/srep37436","journal-title":"Sci Rep"},{"key":"185_CR21","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1096\/fj.201600713R","volume":"31","author":"AE Gonz\u00e1lez","year":"2017","unstructured":"Gonz\u00e1lez AE, Mu\u00f1oz VC, Cavieres VA, Bustamante HA, Cornejo VH, Janu\u00e1rio YC, Gonz\u00e1lez I, Hetz C, daSilva L, Rojas-Fern\u00e1ndez A, Hay RT, Mardones GA, Burgos PV (2017) Autophagosomes cooperate in the degradation of intracellular C-terminal fragments of the amyloid precursor protein via the MVB\/lysosomal pathway. FASEB J 31:2446\u20132459. https:\/\/doi.org\/10.1096\/fj.201600713R","journal-title":"FASEB J"},{"key":"185_CR22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1474-9726.2012.00854.x","volume":"11","author":"M Guglielmotto","year":"2012","unstructured":"Guglielmotto M, Monteleone D, Boido M, Piras A, Giliberto L, Borghi R, Vercelli A, Fornaro M, Tabaton M, Tamagno E (2012) A\u03b21-42-mediated down-regulation of Uch-L1 is dependent on NF-\u03baB activation and impaired BACE1 lysosomal degradation. Aging Cell 11:834\u2013844. https:\/\/doi.org\/10.1111\/j.1474-9726.2012.00854.x","journal-title":"Aging Cell"},{"key":"185_CR23","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/sj.bjp.0705688","volume":"141","author":"YS Han","year":"2004","unstructured":"Han YS, Zheng WH, Bastianetto S, Chabot JG, Quirion R (2004) Neuroprotective effects of resveratrol against \u03b2-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 141:997\u20131005. https:\/\/doi.org\/10.1038\/sj.bjp.0705688","journal-title":"Br J Pharmacol"},{"key":"185_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425\u2013479. https:\/\/doi.org\/10.1146\/annurev.biochem.67.1.425","journal-title":"Annu Rev Biochem"},{"key":"185_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-019-01660-3","volume":"56","author":"MF Hossain","year":"2019","unstructured":"Hossain MF, Uddin MS, Uddin GMS, Sumsuzzman DM, Islam MS, Barreto GE, Mathew B, Ashraf GM (2019) Melatonin in Alzheimer\u2019s disease: a latent endogenous regulator of neurogenesis to mitigate Alzheimer\u2019s neuropathology. Mol Neurobiol 56:1\u201322. https:\/\/doi.org\/10.1007\/s12035-019-01660-3","journal-title":"Mol Neurobiol"},{"key":"185_CR26","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/s0891-5849(03)00062-5","volume":"34","author":"J-H Jang","year":"2003","unstructured":"Jang J-H, Surh Y-J (2003) Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radic Biol Med 34:1100\u20131110. https:\/\/doi.org\/10.1016\/s0891-5849(03)00062-5","journal-title":"Free Radic Biol Med"},{"key":"185_CR27","first-page":"43","volume":"2","author":"UK Jinwal","year":"2010","unstructured":"Jinwal UK, Koren J, O\u2019Leary JC et al (2010) Hsp70 ATPase modulators as therapeutics for Alzheimer\u2019s and other neurodegenerative diseases. Mol Cell Pharmacol 2:43\u201346","journal-title":"Mol Cell Pharmacol"},{"key":"185_CR28","doi-asserted-by":"publisher","first-page":"16976","DOI":"10.1074\/jbc.M110.182493","volume":"286","author":"UK Jinwal","year":"2011","unstructured":"Jinwal UK, Trotter JH, Abisambra JF, Koren J 3rd, Lawson LY, Vestal GD, O'Leary JC 3rd, Johnson AG, Jin Y, Jones JR, Li Q, Weeber EJ, Dickey CA (2011) The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics. J Biol Chem 286:16976\u201316983. https:\/\/doi.org\/10.1074\/jbc.M110.182493","journal-title":"J Biol Chem"},{"key":"185_CR29","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","volume":"143","author":"JA Johnston","year":"1998","unstructured":"Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143:1883\u20131898. https:\/\/doi.org\/10.1083\/jcb.143.7.1883","journal-title":"J Cell Biol"},{"key":"185_CR30","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.2174\/1381612825666191011102444","volume":"25","author":"MT Kabir","year":"2019","unstructured":"Kabir MT, Abu Sufian M, Uddin MS et al (2019a) NMDA receptor antagonists: repositioning of memantine as multitargeting agent for Alzheimer\u2019s therapy. Curr Pharm Des 25:3506\u20133518. https:\/\/doi.org\/10.2174\/1381612825666191011102444","journal-title":"Curr Pharm Des"},{"key":"185_CR31","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.2174\/1381612825666191008103141","volume":"25","author":"MT Kabir","year":"2019","unstructured":"Kabir MT, Uddin MS, Begum MM et al (2019b) Cholinesterase inhibitors for Alzheimer\u2019s disease: multitargeting strategy based on anti-Alzheimer\u2019s drugs repositioning. Curr Pharm Des 25:3519\u20133535. https:\/\/doi.org\/10.2174\/1381612825666191008103141","journal-title":"Curr Pharm Des"},{"key":"185_CR32","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1523\/JNEUROSCI.2422-09.2010","volume":"30","author":"M Kaneko","year":"2010","unstructured":"Kaneko M, Koike H, Saito R, Kitamura Y, Okuma Y, Nomura Y (2010) Loss of HRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloid- generation. J Neurosci 30:3924\u20133932. https:\/\/doi.org\/10.1523\/JNEUROSCI.2422-09.2010","journal-title":"J Neurosci"},{"key":"185_CR33","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1093\/hmg\/ddr091","volume":"20","author":"PJ Khandelwal","year":"2011","unstructured":"Khandelwal PJ, Herman AM, Hoe H-S, Rebeck GW, Moussa CE (2011) Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated A in AD models. Hum Mol Genet 20:2091\u20132102. https:\/\/doi.org\/10.1093\/hmg\/ddr091","journal-title":"Hum Mol Genet"},{"key":"185_CR34","doi-asserted-by":"publisher","first-page":"11006","DOI":"10.1074\/jbc.272.17.11006","volume":"272","author":"T-W Kim","year":"1997","unstructured":"Kim T-W, Pettingell WH, Hallmark OG, Moir RD, Wasco W, Tanzi RE (1997) Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J Biol Chem 272:11006\u201311010. https:\/\/doi.org\/10.1074\/jbc.272.17.11006","journal-title":"J Biol Chem"},{"key":"185_CR35","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.febslet.2009.12.047","volume":"584","author":"VI Korolchuk","year":"2010","unstructured":"Korolchuk VI, Menzies FM, Rubinsztein DC (2010) Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems. FEBS Lett 584:1393\u20131398","journal-title":"FEBS Lett"},{"key":"185_CR36","doi-asserted-by":"publisher","first-page":"9902","DOI":"10.1073\/pnas.170173897","volume":"97","author":"YA Lam","year":"2000","unstructured":"Lam YA, Pickart CM, Alban A et al (2000) Inhibition of the ubiquitin-proteasome system in Alzheimer\u2019s disease. Proc Natl Acad Sci 97:9902\u20139906. https:\/\/doi.org\/10.1073\/pnas.170173897","journal-title":"Proc Natl Acad Sci"},{"key":"185_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/B978-0-12-394816-8.00007-6","volume":"64","author":"RF Lane","year":"2012","unstructured":"Lane RF, Shineman DW, Steele JW et al (2012) Beyond amyloid: the future of therapeutics for Alzheimer\u2019s disease. Adv Pharmacol 64:213-71.","journal-title":"Adv Pharmacol"},{"key":"185_CR38","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1681\/ASN.2006010083","volume":"17","author":"SH Lecker","year":"2006","unstructured":"Lecker SH, Goldberg AL, Mitch WE (2006) Protein degradation by the ubiquitin\u2013proteasome pathway in normal and disease states. J Am Soc Nephrol 17:1807\u20131819. https:\/\/doi.org\/10.1681\/ASN.2006010083","journal-title":"J Am Soc Nephrol"},{"key":"185_CR39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/brain\/114.2.775","volume":"114","author":"PN Leigh","year":"1991","unstructured":"Leigh PN, Whitwell H, Garofalo\u00a0O et al (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Brain 114:775\u2013788. https:\/\/doi.org\/10.1093\/brain\/114.2.775","journal-title":"Brain"},{"key":"185_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1083\/jcb.200111034","volume":"157","author":"K Lindsten","year":"2002","unstructured":"Lindsten K, de Vrij FMS, Verhoef LGGC, Fischer DF, van Leeuwen F, Hol EM, Masucci MG, Dantuma NP (2002) Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J Cell Biol 157:417\u2013427. https:\/\/doi.org\/10.1083\/jcb.200111034","journal-title":"J Cell Biol"},{"key":"185_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/JAD-2012-121141","volume":"33","author":"I Lonskaya","year":"2012","unstructured":"Lonskaya I, Shekoyan AR, Hebron ML et al (2012) Diminished parkin solubility and co-localization with intraneuronal amyloid-\u03b2 are associated with autophagic defects in Alzheimer\u2019s disease. J Alzheimers Dis 33:231\u2013247. https:\/\/doi.org\/10.3233\/JAD-2012-121141","journal-title":"J Alzheimers Dis"},{"key":"185_CR42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00109-013-1112-3","volume":"92","author":"I Lonskaya","year":"2014","unstructured":"Lonskaya I, Hebron ML, Desforges NM et al (2014) Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance. J Mol Med 92:373\u2013386. https:\/\/doi.org\/10.1007\/s00109-013-1112-3","journal-title":"J Mol Med"},{"key":"185_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/495091","volume":"2014","author":"P Maiti","year":"2014","unstructured":"Maiti P, Manna J, Veleri S, Frautschy S (2014) Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin. Biomed Res Int 2014:1\u201314. https:\/\/doi.org\/10.1155\/2014\/495091","journal-title":"Biomed Res Int"},{"key":"185_CR44","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.4103\/1673-5374.274329","volume":"15","author":"AA Mamun","year":"2020","unstructured":"Mamun AA, Uddin MS, Mathew B, Ashraf GM (2020) Toxic tau: structural origins of tau aggregation in Alzheimer\u2019s disease. Neural Regen Res 15:1417\u20131420. https:\/\/doi.org\/10.4103\/1673-5374.274329","journal-title":"Neural Regen Res"},{"key":"185_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF03401912","volume":"4","author":"P Marambaud","year":"1998","unstructured":"Marambaud P, Ancolio K, Lopez-Perez E, Checler F (1998) Proteasome inhibitors prevent the degradation of familial Alzheimer\u2019s disease-linked presenilin 1 and potentiate A beta 42 recovery from human cells. Mol Med 4:147\u2013157","journal-title":"Mol Med"},{"key":"185_CR46","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.1074\/jbc.M508246200","volume":"280","author":"P Marambaud","year":"2005","unstructured":"Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-\u03b2 peptides. J Biol Chem 280:37377\u201337382. https:\/\/doi.org\/10.1074\/jbc.M508246200","journal-title":"J Biol Chem"},{"issue":"11","key":"185_CR47","doi-asserted-by":"publisher","first-page":"1900177","DOI":"10.1002\/ardp.201900177","volume":"352","author":"Bijo Mathew","year":"2019","unstructured":"Mathew B, Parambi DGT, Mathew GE et al (2019) Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer\u2019s and Parkinson\u2019s diseases. Arch Pharm (Weinheim) 352:1\u201313. https:\/\/doi.org\/10.1002\/ardp.201900177","journal-title":"Archiv der Pharmazie"},{"key":"185_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0972-2327.40220","volume":"11","author":"S Mishra","year":"2008","unstructured":"Mishra S, Palanivelu K (2008) The effect of curcumin (turmeric) on Alzheimer\u2019s disease: an overview. Ann Indian Acad Neurol 11:13\u201319. https:\/\/doi.org\/10.4103\/0972-2327.40220","journal-title":"Ann Indian Acad Neurol"},{"key":"185_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12035-012-8246-0","volume":"46","author":"T Morawe","year":"2012","unstructured":"Morawe T, Hiebel C, Kern A, Behl C (2012) Protein homeostasis, aging and Alzheimer\u2019s disease. Mol Neurobiol 46:41\u201354. https:\/\/doi.org\/10.1007\/s12035-012-8246-0","journal-title":"Mol Neurobiol"},{"key":"185_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/bf02705243","volume":"31","author":"D Nandi","year":"2006","unstructured":"Nandi D, Tahiliani P, Kumar A, Chandu D (2006) The ubiquitin-proteasome system. J Biosci 31:137\u2013155. https:\/\/doi.org\/10.1007\/bf02705243","journal-title":"J Biosci"},{"key":"185_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.expneurol.2011.08.009","volume":"232","author":"D Necchi","year":"2011","unstructured":"Necchi D, Lomoio S, Scherini E (2011) Dysfunction of the ubiquitin\u2013proteasome system in the cerebellum of aging Ts65Dn mice. Exp Neurol 232:114\u2013118. https:\/\/doi.org\/10.1016\/j.expneurol.2011.08.009","journal-title":"Exp Neurol"},{"issue":"80","key":"185_CR52","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(80):130\u2013133. https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"key":"185_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/JAD-2001-3114","volume":"3","author":"RA Nixon","year":"2001","unstructured":"Nixon RA, Mathews PM, Cataldo AM (2001) The neuronal endosomal-lysosomal system in Alzheimer\u2019s disease. J Alzheimers Dis 3:97\u2013107","journal-title":"J Alzheimers Dis"},{"key":"185_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1326-5-45","volume":"5","author":"JC O\u2019Leary","year":"2010","unstructured":"O\u2019Leary JC, Li Q, Marinec P et al (2010) Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Mol Neurodegener 5:45. https:\/\/doi.org\/10.1186\/1750-1326-5-45","journal-title":"Mol Neurodegener"},{"key":"185_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/796869","volume":"2014","author":"J-R Ou","year":"2014","unstructured":"Ou J-R, Tan M-S, Xie A-M et al (2014) Heat shock protein 90 in Alzheimer\u2019s disease. Biomed Res Int 2014:1\u20137. https:\/\/doi.org\/10.1155\/2014\/796869","journal-title":"Biomed Res Int"},{"key":"185_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.conb.2006.01.007","volume":"16","author":"GN Patrick","year":"2006","unstructured":"Patrick GN (2006) Synapse formation and plasticity: recent insights from the perspective of the ubiquitin proteasome system. Curr Opin Neurobiol 16:90\u201394. https:\/\/doi.org\/10.1016\/j.conb.2006.01.007","journal-title":"Curr Opin Neurobiol"},{"key":"185_CR57","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev.neuro.21.1.479","volume":"21","author":"DL Price","year":"1998","unstructured":"Price DL, Sisodia SS (1998) Mutant genes in familial Alzheimer\u2019s disease and transgenic models. Annu Rev Neurosci 21:479\u2013505. https:\/\/doi.org\/10.1146\/annurev.neuro.21.1.479","journal-title":"Annu Rev Neurosci"},{"key":"185_CR58","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3233\/JAD-140600","volume":"44","author":"J Renziehausen","year":"2015","unstructured":"Renziehausen J, Hiebel C, Nagel H, Kundu A, Kins S, K\u00f6gel D, Behl C, Hajieva P (2015) The cleavage product of amyloid-\u03b2 protein precursor sA\u03b2PP\u03b1 modulates BAG3-dependent aggresome formation and enhances cellular proteasomal activity. J Alzheimers Dis 44:879\u2013896. https:\/\/doi.org\/10.3233\/JAD-140600","journal-title":"J Alzheimers Dis"},{"key":"185_CR59","doi-asserted-by":"publisher","DOI":"10.4018\/978-1-7998-1317-0","volume-title":"Quality control of cellular protein in neurodegenerative disorders","author":"M Sahab Uddin","year":"2020","unstructured":"Sahab Uddin M, Ashraf GM (2020) Quality control of cellular protein in neurodegenerative disorders. IGI Global, Hershey"},{"key":"185_CR60","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1254\/jphs.10118sc","volume":"113","author":"R Saito","year":"2010","unstructured":"Saito R, Kaneko M, Okuma Y, Nomura Y (2010) Correlation between decrease in protein levels of ubiquitin ligase HRD1 and amyloid-beta production. J Pharmacol Sci 113:285\u2013288. https:\/\/doi.org\/10.1254\/jphs.10118sc","journal-title":"J Pharmacol Sci"},{"key":"185_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pneurobio.2010.10.006","volume":"93","author":"A Salminen","year":"2011","unstructured":"Salminen A, Ojala J, Kaarniranta K, Hiltunen M, Soininen H (2011) Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer\u2019s disease. Prog Neurobiol 93:99\u2013110. https:\/\/doi.org\/10.1016\/j.pneurobio.2010.10.006","journal-title":"Prog Neurobiol"},{"key":"185_CR62","doi-asserted-by":"publisher","unstructured":"Sarah Kishinevsky AC, Wenjie Lou JKI, Koren J et al (2013) Chaperone-dependent neurodegeneration: a molecular perspective on therapeutic intervention. J Alzheimer\u2019s Dis Park s10. https:\/\/doi.org\/10.4172\/2161-0460.S10-007","DOI":"10.4172\/2161-0460.S10-007"},{"key":"185_CR63","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000073766","volume":"49","author":"E Savaskan","year":"2003","unstructured":"Savaskan E, Olivieri G, Meier F, Seifritz E, Wirz-Justice A, M\u00fcller-Spahn F (2003) Red wine ingredient resveratrol protects from \u03b2-amyloid neurotoxicity. Gerontology 49:380\u2013383. https:\/\/doi.org\/10.1159\/000073766","journal-title":"Gerontology"},{"key":"185_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev.pharmtox.051208.165340","volume":"49","author":"AL Schwartz","year":"2009","unstructured":"Schwartz AL, Ciechanover A (2009) Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 49:73\u201396. https:\/\/doi.org\/10.1146\/annurev.pharmtox.051208.165340","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"185_CR65","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/acel.12335","volume":"14","author":"AK Singh","year":"2015","unstructured":"Singh AK, Pati U (2015) CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of \u03b2-secretase. Aging Cell 14:595\u2013604. https:\/\/doi.org\/10.1111\/acel.12335","journal-title":"Aging Cell"},{"key":"185_CR66","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.molcel.2003.08.005","volume":"12","author":"S Song","year":"2003","unstructured":"Song S, Kim S-Y, Hong Y-M, Jo DG, Lee JY, Shim SM, Chung CW, Seo SJ, Yoo YJ, Koh JY, Lee MC, Yates AJ, Ichijo H, Jung YK (2003) Essential role of E2-25K\/Hip-2 in mediating amyloid-\u03b2 neurotoxicity. Mol Cell 12:553\u2013563. https:\/\/doi.org\/10.1016\/j.molcel.2003.08.005","journal-title":"Mol Cell"},{"key":"185_CR67","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1083\/jcb.200711066","volume":"182","author":"S Song","year":"2008","unstructured":"Song S, Lee H, Kam T-I, Tai ML, Lee JY, Noh JY, Shim SM, Seo SJ, Kong YY, Nakagawa T, Chung CW, Choi DY, Oubrahim H, Jung YK (2008) E2-25K\/Hip-2 regulates caspase-12 in ER stress\u2013mediated A\u03b2 neurotoxicity. J Cell Biol 182:675\u2013684. https:\/\/doi.org\/10.1083\/jcb.200711066","journal-title":"J Cell Biol"},{"key":"185_CR68","doi-asserted-by":"publisher","first-page":"32322","DOI":"10.1074\/jbc.273.48.32322","volume":"273","author":"H Steiner","year":"1998","unstructured":"Steiner H, Capell A, Pesold B, Citron M, Kloetzel PM, Selkoe DJ, Romig H, Mendla K, Haass C (1998) Expression of Alzheimer\u2019s disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J Biol Chem 273:32322\u201332331. https:\/\/doi.org\/10.1074\/jbc.273.48.32322","journal-title":"J Biol Chem"},{"key":"185_CR69","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1517\/14728222.2013.791284","volume":"17","author":"M Takalo","year":"2013","unstructured":"Takalo M, Haapasalo A, Natunen T, Viswanathan J, Kurkinen KM, Tanzi RE, Soininen H, Hiltunen M (2013) Targeting ubiquilin-1 in Alzheimer\u2019s disease. Expert Opin Ther Targets 17:795\u2013810. https:\/\/doi.org\/10.1517\/14728222.2013.791284","journal-title":"Expert Opin Ther Targets"},{"key":"185_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2756068","volume":"2016","author":"A Tramutola","year":"2016","unstructured":"Tramutola A, Di Domenico F, Barone E et al (2016) It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease. Oxidative Med Cell Longev 2016:1\u201312. https:\/\/doi.org\/10.1155\/2016\/2756068","journal-title":"Oxidative Med Cell Longev"},{"key":"185_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2019.00197","volume":"7","author":"MS Uddin","year":"2019","unstructured":"Uddin MS, Kabir MT (2019) Emerging signal regulating potential of genistein against Alzheimer\u2019s disease: a promising molecule of interest. Front Cell Dev Biol 7:1\u201312. https:\/\/doi.org\/10.3389\/fcell.2019.00197","journal-title":"Front Cell Dev Biol"},{"key":"185_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000481812","volume":"25","author":"MS Uddin","year":"2018","unstructured":"Uddin MS, Al Mamun A, Asaduzzaman M et al (2018a) Spectrum of disease and prescription pattern for outpatients with neurological disorders: an empirical pilot study in Bangladesh. Ann Neurosci 25:25\u201337. https:\/\/doi.org\/10.1159\/000481812","journal-title":"Ann Neurosci"},{"key":"185_CR73","doi-asserted-by":"publisher","unstructured":"Uddin MS, Stachowiak A, Al Mamun A et al (2018b) Autophagy and Alzheimer\u2019s disease: from molecular mechanisms to therapeutic implications. Front Aging Neurosci 10:1\u201318. https:\/\/doi.org\/10.3389\/fnagi.2018.00004","DOI":"10.3389\/fnagi.2018.00004"},{"key":"185_CR74","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1007\/s12035-018-1420-2","volume":"56","author":"MS Uddin","year":"2019","unstructured":"Uddin MS, Al Mamun A, Kabir MT et al (2019a) Nootropic and anti-Alzheimer\u2019s actions of medicinal plants: molecular insight into therapeutic potential to alleviate Alzheimer\u2019s neuropathology. Mol Neurobiol 56:4925\u20134944. https:\/\/doi.org\/10.1007\/s12035-018-1420-2","journal-title":"Mol Neurobiol"},{"key":"185_CR75","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","volume":"56","author":"MS Uddin","year":"2019","unstructured":"Uddin MS, Kabir MT, Al Mamun A et al (2019b) APOE and Alzheimer\u2019s disease: evidence mounts that targeting APOE4 may combat Alzheimer\u2019s pathogenesis. Mol Neurobiol 56:2450\u20132465. https:\/\/doi.org\/10.1007\/s12035-018-1237-z","journal-title":"Mol Neurobiol"},{"key":"185_CR76","doi-asserted-by":"publisher","first-page":"8094","DOI":"10.1002\/jcp.27588","volume":"234","author":"MS Uddin","year":"2019","unstructured":"Uddin MS, Mamun AA, Labu ZK et al (2019c) Autophagic dysfunction in Alzheimer\u2019s disease: cellular and molecular mechanistic approaches to halt Alzheimer\u2019s pathogenesis. J Cell Physiol 234:8094\u20138112. https:\/\/doi.org\/10.1002\/jcp.27588","journal-title":"J Cell Physiol"},{"key":"185_CR77","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/psyg.12368","volume":"19","author":"MS Uddin","year":"2019","unstructured":"Uddin MS, Mamun AA, Takeda S et al (2019d) Analyzing the chance of developing dementia among geriatric people: a cross-sectional pilot study in Bangladesh. Psychogeriatrics 19:87\u201394. https:\/\/doi.org\/10.1111\/psyg.12368","journal-title":"Psychogeriatrics"},{"key":"185_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scitotenv.2019.134836","volume":"700","author":"MS Uddin","year":"2020","unstructured":"Uddin MS, Kabir MT, Tewari D et al (2020a) Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer\u2019s disease. Sci Total Environ 700:1\u201311.\u00a0https:\/\/doi.org\/10.1016\/j.scitotenv.2019.134836","journal-title":"Sci Total Environ"},{"key":"185_CR79","doi-asserted-by":"publisher","first-page":"135624","DOI":"10.1016\/j.scitotenv.2019.135624","volume":"707","author":"Md. Sahab Uddin","year":"2020","unstructured":"Uddin MS, Mamun AA1, Jakaria M et al (2020b) Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders. Sci Total Environ 707:1\u201312. \u00a0https:\/\/doi.org\/10.1016\/j.scitotenv.2019.135624","journal-title":"Science of The Total Environment"},{"key":"185_CR80","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.2174\/138161205774580651","volume":"11","author":"S Upadhya","year":"2005","unstructured":"Upadhya S, Hegde A (2005) Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies. Curr Pharm Des 11:3807\u20133828. https:\/\/doi.org\/10.2174\/138161205774580651","journal-title":"Curr Pharm Des"},{"issue":"80","key":"185_CR81","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.279.5348.242","volume":"279","author":"FW van Leeuwen","year":"1998","unstructured":"van Leeuwen FW, de Kleijn DPV, van den Hurk HH et al (1998) Frameshift mutants of \u03b2 amyloid precursor protein and ubiquitin-B in Alzheimer\u2019s and down patients. Science 279(80):242\u2013247. https:\/\/doi.org\/10.1126\/science.279.5348.242","journal-title":"Science"},{"key":"185_CR82","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13041-015-0155-5","volume":"8","author":"J Vriend","year":"2015","unstructured":"Vriend J, Ghavami S, Marzban H (2015) The role of the ubiquitin proteasome system in cerebellar development and medulloblastoma. Mol Brain 8:64. https:\/\/doi.org\/10.1186\/s13041-015-0155-5","journal-title":"Mol Brain"},{"key":"185_CR83","doi-asserted-by":"publisher","first-page":"E3129","DOI":"10.1073\/pnas.1618804114","volume":"114","author":"BJ Wang","year":"2017","unstructured":"Wang BJ, Her GM, Hu MK, Chen YW, Tung YT, Wu PY, Hsu WM, Lee H, Jin LW, Hwang SL, Chen RP, Huang CJ, Liao YF (2017) ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 114:E3129\u2013E3138. https:\/\/doi.org\/10.1073\/pnas.1618804114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"185_CR84","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12035-007-0029-7","volume":"35","author":"MMM Wilhelmus","year":"2007","unstructured":"Wilhelmus MMM, de Waal RMW, Verbeek MM (2007) Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer\u2019s disease. Mol Neurobiol 35:203\u2013216","journal-title":"Mol Neurobiol"},{"key":"185_CR85","doi-asserted-by":"publisher","first-page":"12137","DOI":"10.1523\/JNEUROSCI.0705-15.2015","volume":"35","author":"Q Xiao","year":"2015","unstructured":"Xiao Q, Yan P, Ma X, Liu H, Perez R, Zhu A, Gonzales E, Tripoli DL, Czerniewski L, Ballabio A, Cirrito JR, Diwan A, Lee JM (2015) Neuronal-targeted TFEB accelerates lysosomal degradation of app, reducing A\u03b2 generation and amyloid plaque pathogenesis. J Neurosci 35:12137\u201312151. https:\/\/doi.org\/10.1523\/JNEUROSCI.0705-15.2015","journal-title":"J Neurosci"},{"key":"185_CR86","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/brain\/awq341","volume":"134","author":"D-S Yang","year":"2011","unstructured":"Yang D-S, Stavrides P, Mohan PS et al (2011) Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer\u2019s disease ameliorates amyloid pathologies and memory deficits. Brain 134:258\u2013277. https:\/\/doi.org\/10.1093\/brain\/awq341","journal-title":"Brain"},{"key":"185_CR87","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1080\/15548627.2017.1379633","volume":"13","author":"C Yang","year":"2017","unstructured":"Yang C, Cai CZ, Song JX, Tan JQ, Durairajan SSK, Iyaswamy A, Wu MY, Chen LL, Yue Z, Li M, Lu JH (2017) NRBF2 is involved in the autophagic degradation process of APP-CTFs in Alzheimer disease models. Autophagy 13:2028\u20132040. https:\/\/doi.org\/10.1080\/15548627.2017.1379633","journal-title":"Autophagy"},{"key":"185_CR88","doi-asserted-by":"publisher","unstructured":"Zhang M, Deng Y, Luo Y et al (2012) Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1. J Neurochem 120. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07644.x","DOI":"10.1111\/j.1471-4159.2011.07644.x"},{"key":"185_CR89","doi-asserted-by":"publisher","first-page":"7298","DOI":"10.1038\/srep07298","volume":"4","author":"M Zhang","year":"2015","unstructured":"Zhang M, Cai F, Zhang S, Zhang S, Song W (2015) Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer\u2019s progression in vivo. Sci Rep 4:7298\u20137296. https:\/\/doi.org\/10.1038\/srep07298","journal-title":"Sci Rep"},{"key":"185_CR90","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/s0960-9822(03)00332-4","volume":"13","author":"Y Zhao","year":"2003","unstructured":"Zhao Y, Hegde AN, Martin KC (2003) The ubiquitin proteasome system functions as an inhibitory constraint on synaptic strengthening. Curr Biol 13:887\u2013898. https:\/\/doi.org\/10.1016\/s0960-9822(03)00332-4","journal-title":"Curr Biol"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-020-00185-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-020-00185-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-020-00185-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:10:53Z","timestamp":1615248653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-020-00185-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1007\/s12640-020-00185-1","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"27 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}